Vivekanand Biotechnics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 114.94%
(FY 2019)
- Profit 101.14%
(FY 2019)
- Ebitda 127.39%
(FY 2019)
- Net Worth 0.81%
(FY 2019)
- Total Assets -2.62%
(FY 2019)
About Vivekanand Biotechnics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Gagare, Akshay Rokade, and Ajinkya Naikwade serve as directors at the Company.
- CIN/LLPIN
U24304MH2016PTC285533
- Company No.
285533
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2016
- Date of AGM
25 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Vivekanand Biotechnics Private Limited offer?
Vivekanand Biotechnics Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Water Treatment Chemicals, Water Treatment & Purification Plant, Sewage Treatment Plants.
Who are the key members and board of directors at Vivekanand Biotechnics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Rokade  | Director | 15-Sep-2017 | Current |
| Santosh Gagare | Director | 05-Sep-2016 | Current |
| Ajinkya Naikwade | Director | 15-Sep-2017 | Current |
Financial Performance of Vivekanand Biotechnics.
Vivekanand Biotechnics Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 114.94% increase. The company also saw a substantial improvement in profitability, with a 101.14% increase in profit. The company's net worth moved up by a moderate rise of 0.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivekanand Biotechnics?
In 2019, Vivekanand Biotechnics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vivekanand Biotechnics?
Unlock and access historical data on people associated with Vivekanand Biotechnics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivekanand Biotechnics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivekanand Biotechnics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
